Ignoring good manufacturing practices warnings landed Triceuticals Inc. in hot water with FDA, and a consumer’s kidney failure associated with a product containing “high levels of vitamin D” helped catch the Department of Justice’s attention.
Triceuticals and its president, Liqun Zhang, agreed to a consent decree permanently preventing them from manufacturing and distributing adulterated dietary supplements, DoJ announced July 9. The decree entered in New...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?